  |
 | Up a level |
Oza, Amit M. and Lorusso, Domenica and Oaknin, Ana and Safra, Tamar and Swisher, Elizabeth M. and Bondarenko, Igor M. and Huzarski, Tomasz and Klat, Jaroslav and Póka, Róbert and Viola, Luciana S. and Tankersley, Chris and Maloney, Lara and Goble, Sandra and Unger, Caro and Giordano, Heidi and Kristeleit, Rebecca S. (2017) ARIEL4: An International, Multicenter, Randomized Phase 3 Study of the PARP Inhibitor Rucaparib vs Chemotherapy in Germline or Somatic BRCA1- or BRCA2-Mutated, Relapsed, High-Grade Ovarian Carcinoma. Journal of Clinical Oncology, 35 (15). TPS5603- TPS5603. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Finn, Richard S. and Crown, John P. and Ettl, Johannes and Bondarenko, Igor M. and Lang, Istvan and Pinter, Tamas and Boer, Katalin and Patel, Ravindranath and Randolph, Sophia and Kim, Sindy T. and Huang, Xin and Schnell, Patrick and Nadanaciva, Sashi and Bartlett, Cynthia Huang and Slamon, Dennis J. (2016) Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. Breast Cancer Research, 18 (67). pp. 1-14. ISSN 1465-542X
